NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $530,000 | +113.7% | 6,707 | +103.2% | 0.03% | +4.0% |
| Q4 2021 | $248,000 | -35.2% | 3,300 | 0.0% | 0.02% | -43.2% |
| Q3 2021 | $383,000 | -2.5% | 3,300 | +10.9% | 0.04% | -22.8% |
| Q2 2021 | $393,000 | 0.0% | 2,975 | 0.0% | 0.06% | -18.6% |
| Q1 2021 | $393,000 | -36.9% | 2,975 | -17.4% | 0.07% | -43.1% |
| Q4 2020 | $623,000 | +63.5% | 3,600 | +5.1% | 0.12% | +30.9% |
| Q3 2020 | $381,000 | +62.8% | 3,425 | -13.3% | 0.09% | +30.6% |
| Q2 2020 | $234,000 | -45.3% | 3,950 | -37.8% | 0.07% | -52.9% |
| Q1 2020 | $428,000 | -20.0% | 6,350 | 0.0% | 0.15% | +3.4% |
| Q4 2019 | $535,000 | – | 6,350 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |